gene therapy
Stilla Technologies, Source BioScience Partner to Bring Digital PCR Services to the UK, Ireland
Source BioScience will provide digital PCR services for biopharma and clinical research customers in these countries using Stilla's Nio system.
Editas Medicine Raises $57M by Selling Future Payments From CRISPR Licensing Deal With Vertex Pharma
Editas will receive $57 million in upfront cash from DRI Healthcare Trust in exchange for certain future licensing fees and payments it is owed under an earlier deal with Vertex.
Tome Biosciences to Lay off 131 Employees
The Watertown, Massachusetts-based genome editing firm has raised $213 million between its Series A and Series B financing rounds.
Integrated DNA Technologies Licenses CRISPR Off-Target Detection Technology From SeQure Dx
The sequencing-based method for unbiased off-target analysis was developed in Keith Joung's lab at Massachusetts General Hospital.
Abu Dhabi Health Department, Opus Genetics Strike Gene Therapy Collaboration for Retinal Diseases
The organizations will explore opportunities to conduct preclinical and clinical trials in the UAE and leverage the UAE's genome program.